Ranked by reported Q4 2024 13F market value
Share of total reported institutional value in ATXI held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Ikarian Capital, LLC | 140K | $280K | — | 4.249% | 0.10% |
| 2 | BOOTHBAY FUND MANAGEMENT, LLC | 41K | $82K | — | 1.247% | 0.00% |
| 3 | UBS Group AG | 8K | $16K | +28.9% | 0.240% | 0.00% |
| 4 | Tower Research Capital LLC (TRC) | 3K | $6K | +77.9% | 0.094% | 0.00% |
| 5 | WELLS FARGO & COMPANY/MN | 500 | $1K | -10.9% | 0.015% | 0.00% |
| 6 | BANK OF AMERICA CORP /DE/ | 14 | $28 | +40.0% | 0.000% | 0.00% |
| 7 | SBI Securities Co., Ltd. | 9 | $18 | — | 0.000% | 0.00% |
| 8 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | — | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in ATXI — a direct measure of their conviction.
Filings activity in ATXI during Q4 2024, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q4 2024 | 8 | 11% | 36.54% | 10.10 pp | $0M | 22% |
| Q3 2024 | 9 | 10% | 46.64% | +8.02 pp | $0M | +21% |
| Q2 2024 | 10 | 33% | 38.62% | +23.17 pp | $0M | +150% |
| Q1 2024 | 15 | 48% | 15.45% | 184.54 pp | $0M | 95% |
| Q2 2021 | 29 | 19% | 199.99% | +0.00 pp | $3M | 80% |
| Q1 2021 | 36 | +0.0% | 199.99% | +0.00 pp | $16M | 13% |
| Q4 2020 | 36 | +9.1% | 199.99% | +0.00 pp | $18M | 58% |
| Q3 2020 | 33 | — | 199.99% | — | $44M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying ATXI stock.
Based on Q4 2024 13F filings, institutional ownership of Avenue Therapeutics, Inc. stands at 36.5%, held across 8 reporting institutions.
Ikarian Capital, LLC is the largest reported institutional holder of ATXI, with approximately 140,000 shares worth $0.00B as of Q4 2024.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of ATXI.
Our composite Smart Money Score for ATXI is 21 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
3 institutions opened new positions in ATXI during Q4 2024, while 4 fully exited. 3 added to existing positions and 1 trimmed.
ATXI institutional ownership fell by 10.10 percentage points quarter-over-quarter, with a net change of -1 holders.
The top 10 institutions account for 100.0% of all reported 13F value in ATXI, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Avenue Therapeutics, Inc. (ATXI) Institutional Ownership